<HTML>
<HEAD>
<TITLE>TODAY *5:30pm* BUSA Faculty Lecture/Dinner featuring Professor Rudolf Jaenisch - 68-121</TITLE>
</HEAD>
<BODY>
<BLOCKQUOTE><FONT FACE="Verdana, Helvetica, Arial"><SPAN STYLE='font-size:12.0px'><BR>
<BR>
<BR>
<BR>
MIT Biology Undergraduate Student Association (BUSA) presents...<BR>
</SPAN></FONT>
<P ALIGN=CENTER>
<FONT FACE="Verdana, Helvetica, Arial"><FONT SIZE="7"><SPAN STYLE='font-size:26.0px'>Stem Cells, Reprogramming, Therapy: Promise, Problems, Reality
</SPAN></FONT></FONT>
<P>
<FONT FACE="Verdana, Helvetica, Arial"><SPAN STYLE='font-size:12.0px'>
</SPAN></FONT>
<P ALIGN=CENTER>
<FONT FACE="Verdana, Helvetica, Arial"><FONT SIZE="6"><SPAN STYLE='font-size:24.0px'> <I>BUSA faculty lecture/dinner featuring Professor Rudolph Jaenisch
</I></SPAN></FONT></FONT>
<P>
<FONT FACE="Verdana, Helvetica, Arial"><SPAN STYLE='font-size:12.0px'><BR>
</SPAN></FONT>
<P ALIGN=CENTER>
<FONT FACE="Verdana, Helvetica, Arial"><FONT SIZE="6"><SPAN STYLE='font-size:21.0px'>TODAY - Thursday April 23th, 2009
</SPAN></FONT></FONT>
<P>
<FONT FACE="Verdana, Helvetica, Arial"><SPAN STYLE='font-size:12.0px'>
</SPAN></FONT>
<P ALIGN=CENTER>
<FONT FACE="Verdana, Helvetica, Arial"><FONT SIZE="6"><SPAN STYLE='font-size:21.0px'>5:30pm 68-121
</SPAN></FONT></FONT>
<P>
<FONT FACE="Verdana, Helvetica, Arial"><SPAN STYLE='font-size:12.0px'>
</SPAN></FONT>
<P ALIGN=CENTER>
<FONT FACE="Verdana, Helvetica, Arial"><FONT SIZE="6"><SPAN STYLE='font-size:21.0px'><I>Sushi will be served after the lecture
</I></SPAN></FONT></FONT>
<P>
<FONT FACE="Verdana, Helvetica, Arial"><SPAN STYLE='font-size:12.0px'><BR>
Nuclear cloning holds the promise for generating “customized” ES cells that could be used for research of complex human diseases as well as for transplantation medicine. However, technical and ethical problems impede the application of this technology as approach for the treatment of degenerative diseases. A key question of the field is the molecular mechanism of reprogramming of the somatic nucleus following transfer into the egg. More recently, strategies have been developed that allow direct reprogramming of somatic cells to a pluripotent state without requiring exposure to the egg. The reprogrammed cells have been coined “induced Pluripotent Stem cells” (iPS) and have been shown in animal models to effectively treat major diseases such as Sickle Cell Anemia or Parkinson’s. It is likely that the iPS technology will revolutionize how we study complex human diseases and will provide novel therapeutic strategies.<BR>
<BR>
Open to undergrads of all majors! We look forward to seeing you at this event.<BR>
</SPAN></FONT></BLOCKQUOTE><FONT FACE="Verdana, Helvetica, Arial"><SPAN STYLE='font-size:12.0px'><BR>
</SPAN></FONT>
</BODY>
</HTML>